# Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

> **NCT00107523** · PHASE1 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center**

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** cytarabine
- **DRUG:** idarubicin
- **DRUG:** pravastatin

## Key facts

- **NCT ID:** NCT00107523
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** — (—)
- **Last updated:** 2010-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107523, "Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00107523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*